Vincentage sees 12.4% weight loss for oral GLP-1, will chase Lilly to Chinese regulators

Vincentage Pharma’s oral GLP-1 agonist has been tied to mean weight loss of 12.4% over a year, setting up the biotech to pursue Eli Lilly’s orforglipron to Chin...